GM-1020

· Gilgamesh Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GM-1020, covering 2025-12-16 to 2025-12-16. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study to Evaluate of Single and Multiple Oral Doses of GM-1020 in Patients With MDD [Phase 2]